Search

everythinglearnresearchcommunity

for

Search:↓

Intralesional triamcinolone acetonide is effective for treating patchy hair loss, and dermoscopy helps detect treatment response and side effects early.

Minoxidil effectively treats female pattern hair loss.

Metformin taken during pregnancy increases SHBG in newborns but doesn't change other hormone levels in mothers or babies.

Hair growth slows and shedding increases after childbirth, but most women don't experience excessive hair loss.

Certain 4-azasteroids are effective at blocking the enzyme that processes testosterone in human skin and could help treat acne, excessive hair growth, and male pattern baldness.

Improved dermabrasion techniques in 1987 led to better treatment results for skin issues like acne scars.

PRP treatment improves hair density and thickness for alopecia, but needs more research.

Platelet-Rich Plasma (PRP) shows promise for treating various skin conditions, but more research is needed to standardize its use.

Metformin improves menstrual cycles and hormone levels in women with PCOS, mostly within the first 6 months.

SJS/TEN survivors often have severe, overlooked long-term physical problems that are not properly treated after leaving the hospital.

Measuring reproductive hormones in brown bear hair could help identify their sex and reproductive state, but better collection methods or lab techniques are needed.

High afamin levels are linked to metabolic syndrome and may predict its development in women with insulin resistance.

Pioglitazone usually doesn't effectively treat or cure lichen planopilaris.

Finasteride reduces hair growth and is safe for women with excessive hair.

Minoxidil helps treat eyebrow thinning, monilethrix, early hair loss, and shortens chemo-related hair loss.

Women with polycystic ovary syndrome tend to have a longer anogenital distance.

Women with severe types of PCOS are more likely to have metabolic syndrome, and belly fat is a key predictor of this risk.

Spironolactone is better than placebo for reducing excessive hair growth in women, but its effectiveness for acne is unclear due to small study sizes.

Curcumin may improve blood sugar levels and cholesterol in people with PCOS, but more research is needed.

Patients with chronic skin conditions on systemic treatments did not have worse COVID-19 outcomes and could resume their treatments after recovery.

Low-level light therapy safely improves hair coverage, thickness, and count in androgenetic alopecia patients.

Stress activates a special function of the Vitamin D receptor with the help of c-Jun, which can also prevent cell death.

People who carry the 21-Hydroxylase Deficiency gene are not more likely to have excessive male hormone levels.

Fibrosing alopecia in a pattern distribution is a hair loss condition often confused with other types, requiring early treatment but usually not resulting in significant hair regrowth.

The document concludes that managing non-classical congenital adrenal hyperplasia in females requires personalized treatment, genetic counseling, and a team of specialists.

The study concluded that both anti-Mullerian hormone and LH/FSH ratio are higher in women with PCOS and combining these markers with BMI could improve diagnosis accuracy.

Young women with PCOS have a higher risk of high blood pressure and metabolic syndrome, but these risks may decrease after age 40.

SVF-enhanced adipose transplantation shows potential as a hair loss treatment.

MALDI Imaging Mass Spectrometry is a useful method for studying skin conditions, but sample preparation is crucial for accurate results.

Taking 5-α reductase inhibitors for prostate enlargement or hair loss does not significantly raise the risk of erectile dysfunction.